MJUS News and Press, ETFMG U.S. Alternative Harvest ETF From 12/07/21

Announced acquisition of New Mexico’s 2nd largest operator. Additionally announced a $95M financing to fund transaction and other M&A opportunities. New Mexico to be a high growth state in ’22 as rec sales commence in late March at the latest. Schwazze now we...

It's an appropriate time to take stock of the developments in the cannabis industry. One year in cannabis can feel like several given the many ups and downs that take place in a 12 month span. 2021 delivered a mixed bag of wins and losses. For further details see: 2021 -...

Q3 results impacted by CA pricing but reflect execution. Urbn Leaf acquisition expands retail presence particularly in Southern CA. Loudpack enhances production capabiltiies and brand portfolio. Deals follow acquisitions of Sublime brands and cultivation assets in recent months. ...

Jon DeCourcey, formerly of Canaccord now with Viridian Capital Advisors, joins us to discuss recent cannabis earnings and why he favors mid-tier multi-state operators (MSOs) over the Big 5. SAFE Banking expectations, how he sees valuations growing. Why retail investors should be e...

GAGE growing with retail and cultivation assets in MI. TerrAscend deal poised to close in early ’22. Reduce rating to hold and price target to $1.91 reflecting TerrAscend deal. Potential for upside in short term on TerrAscend stock gains on legislative news or additiona...

Kristen Yoder, host of The CannaBS Detector and a veteran of the industry, gives an unvarnished take on the cannabis industry. Kristen's #1 complaint about the industry. Why she'd rather be short cannabis stocks than long and where she does feel comfortable putting her money. ...

Timely, edifying episode with industry expert Brady Cobb. Recent cannabis legislation; moving from optics to real reform. SAFE Banking, uplisting and what it all means for cannabis investors. MSOs, ETFs new and old, future valuations, Florida and NY/NJ markets. Selling to Cres...

Q3 results in line with estimates. 22 Target Revenue remains $800M, adjusted EBITDA guidance reduced on low end, now at $250M to $300M (was $300M). Expanding presence in IL with Dispensary 33 acquisition. Confident that additional M&A looms given management interest and ca...

An executive panel discussion that makes sense of cannabis investing today, including the recent Republican led bill, JPMorgan trading restrictions and SAFE banking. All star panel includes Blake Schroeder, CEO of Medical Marijuana, Luis Merchan, CEO of Flora Growth and Becky Postar, ...

Greenlane Holdings and KushCo recently merged to become one of the biggest makers of cannabis accessories. CEO Nick Kovacevich on margins and why the merger made sense. Getting to profitability and the broader sell-off in cannabis. For further details see: Greenlane CEO ...